SpaceOAR System
The need to reliably target cancerous tissues while minimizing injury to healthily structures is
key to safe and effective radiotherapy (RT).

Tumor irradiation can sometimes result in injury of healthy tissues (OAR - Organs At Risk).
The presence of nearby healthy tissues often force clinicians into a compromise - deliver enough
radiation to kill the cancer, or reduce the radiation to have acceptable side effects.

To answer this challenge in prostate RT, the SpaceOAR® System, an
absorbable hydrogel that temporarily moves the rectum away from the prostate and the high
intensity radiation zone. This extra space reduces irradiation of healthy tissues, allowing
clinicians to focus on their main objective - killing the cancer.

SpaceOAR System was FDA Cleared on April 1, 2015. See link below for the Instructions for
Use for a complete list of potential risks, warnings and precautions.